Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Syst Rev ; 13(1): 159, 2024 Jun 18.
Artículo en Inglés | MEDLINE | ID: mdl-38890755

RESUMEN

BACKGROUND: Patients with heart failure with preserved ejection fraction (HFpEF) commonly experience exercise intolerance, resulting in reduced cardiorespiratory fitness. This is characterised by a decreased maximal oxygen uptake (V̇O2peak), which is determined by the product of cardiac output (CO) and arteriovenous oxygen difference (a-vDO2). While exercise training has been shown to improve V̇O2peak in HFpEF patients, the effects on CO remain unclear. The aim of this study is to systematically review and analyse the current evidence on the effects of supervised exercise training on CO in patients with HFpEF. METHODS: We will systematically search for literature describing the effects of supervised exercise training on CO in patients with HFpEF. All eligible studies published before 30 June 2023 in the following electronic databases will be included: MEDLINE (Ovid), Embase (Ovid), SPORTDiscus (EBSCOhost), and CENTRAL (Cochrane Library). Effect sizes will be extracted for CO before and after a supervised exercise training intervention at rest and maximal exercise. Mass of heterogeneity (I2) will be calculated, and either fixed-effect models or random-effect models will be used for meta-analysis. To detect a potential publication bias, funnel plot analyses will be performed. DISCUSSION: While several studies have reported a positive effect of supervised exercise training on cardiorespiratory fitness, attempts to assess the underlying determinants of V̇O2peak, CO, and a-vDO2 are much scarcer, especially in patients with HFpEF. From a physiological perspective, measuring CO before and after supervised exercise training seems to be a reasonable way to accurately operationalise a potential improvement in cardiac function. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42022361485.


Asunto(s)
Gasto Cardíaco , Terapia por Ejercicio , Insuficiencia Cardíaca , Metaanálisis como Asunto , Volumen Sistólico , Revisiones Sistemáticas como Asunto , Humanos , Insuficiencia Cardíaca/fisiopatología , Insuficiencia Cardíaca/terapia , Volumen Sistólico/fisiología , Gasto Cardíaco/fisiología , Terapia por Ejercicio/métodos , Consumo de Oxígeno/fisiología , Tolerancia al Ejercicio/fisiología , Capacidad Cardiovascular/fisiología
2.
Phytother Res ; 17(4): 345-7, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12722137

RESUMEN

From leaves of Leea guineense (Leeaceae) three hydrophilic flavonoids were isolated and identified as quercetin-3'-sulphate-3-O-alpha-L-rhamnopyranoside, quercetin-3,3'-disulphate and a new flavonoid sulphate, quercetin-3,3',4'-trisulphate, together with kaempferol, quercetin, quercitrin, mearnsitrin, gallic acid and ethyl gallate. The structures were established by spectroscopic analysis (UV, MS, (1)H-NMR, (13)C-NMR and 2D-NMR). Their antioxidant effect on free radical scavenging was evaluated in the DPPH assay.


Asunto(s)
Antioxidantes/farmacología , Depuradores de Radicales Libres/farmacología , Fitoterapia , Extractos Vegetales/farmacología , Vitaceae , Antioxidantes/administración & dosificación , Antioxidantes/uso terapéutico , Compuestos de Bifenilo , Flavonoides/administración & dosificación , Flavonoides/farmacología , Flavonoides/uso terapéutico , Depuradores de Radicales Libres/administración & dosificación , Depuradores de Radicales Libres/uso terapéutico , Humanos , Hidroxibenzoatos/administración & dosificación , Hidroxibenzoatos/farmacología , Hidroxibenzoatos/uso terapéutico , Espectroscopía de Resonancia Magnética , Picratos , Extractos Vegetales/administración & dosificación , Extractos Vegetales/uso terapéutico , Hojas de la Planta
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA